Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 9, 2026

Study offers insight into how long-term inflammation may contribute to cognitive decline

Is your competent? doctor testing for this AND HAS EXACT PROTOCOLS TO STOP THE INFLAMMATION? NO? So, escaping responsibility and just blaming the stroke for your cognitive decline! I'd suggest screaming and talking to the president to get this person fired! 

 Study offers insight into how long-term inflammation may contribute to cognitive decline

The King's College London study, published in Nature Communications, offers insight into how long-term inflammation may contribute to cognitive decline in disorders such as Alzheimer's disease, aging, depression, and the lingering neurological effects of viral infections.

The scientists discovered that adding a molecule, that is involved in the inflammatory response, to stem cells from the hippocampus prevents the development of new neurons. The formation of new neurons in this region, known as hippocampal neurogenesis, is essential for learning, memory and mood regulation. It is one of the few parts of the human brain where new neurons are made in adults. Altered adult hippocampal neurogenesis is associated with aging, neurodegeneration, and mood disorders such as depression.

The study focused on cytokines, which are chemical signals that are released by the body in response to a threat, such as a viral infection. Cytokines ultimately act as triggers for the rest of the immune response, which helps the body fight the infection. High cytokine levels are also a hallmark of chronic inflammation.

Viral infection has previously been linked to changes in the ability to create new neurons in part of the hippocampus. However, how exactly infection and inflammatory cytokines affect creation of new neurons was previously unknown.

When researchers added one particular cytokine, called TNF‑α, to human hippocampal stem cells, it prevented them from developing into neurons. Instead, they switched into an "immune alert" state, releasing signals that can attract key immune cells, known as T cells, that drive inflammation, while simultaneously reducing the production of new nerve cells.

First author Dr Tinne A. D. Nissen, who completed the research as part of her PhD at King's College London, said: "What surprised us most was that the stem cells were not simply impaired by inflammation, they actively adopted behaviors that could potentially sustain immune responses in the brain."

Our findings reveal a new link between chronic inflammation and the brain's reduced ability to generate new neurons.

Inflammatory signals can effectively redirect hippocampal stem cells away from their normal role of producing neurons and toward supporting immune activity instead."

Professor Sandrine Thuret, co-corresponding author, Professor of Neuroscience, King's College London

The researchers also identified an unexpected signalling pathway behind this effect involving type I interferons, molecules typically associated with the body's antiviral defense. By blocking interferon signalling with an existing therapeutic antibody, some of the effects of inflammation were reversed – by restoring production of new neurons and preventing the attraction of T cells involved in the immune response.

Co-corresponding author Professor Linda S. Klavinskis, Professor of Viral Immunology, King's College London, added: "Our work uncovers a new mechanism that may help explain why ongoing inflammation is so damaging to brain health. Importantly, it also points to possible treatments to protect or restore the brain's regenerative capacity."

This research was a collaboration between the Department of Infectious Diseases at the Faculty of Life Sciences & Medicine and the Department of Basic and Clinical Neuroscience at the Institute of Psychiatry, Psychology & Neuroscience, King's College London.

This research was funded by the Wellcome Trust as part of the "Neuro-Immune Interactions in Health & Disease Wellcome Trust PhD Programme, the Medical Research Council UK, a Medical Research Council Discovery Award, a PhD Studentship awarded by the Medical Research Council UK, The Galen and Hilary Weston Foundation, the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London.

Source:
Journal reference:

Nissen, T. A. D., et al. (2026) TNF-α induces type I IFN signalling to suppress neurogenesis and recruit T cells. Nature Communications. DOI: 10.1038/s41467-026-74104-x. https://www.nature.com/articles/s41467-026-74104-x

No comments:

Post a Comment